GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CAC · Dec 31, 2025

CAMDEN NATIONAL CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000750686-26-000010Bank
Sequential deposit growth80thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

2.50% · CORE · VALID

Net-income growth80thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

22.93% · CORE · VALID

Interest-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

28.49% · CORE · VALID

Cash and equivalents25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$97.5M · CORE · VALID

Sequential loan growth10thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-0.76% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History30 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-2.03%
Current
2.50%
Delta
4.53%
Earnings Growth Decreased
Previous
62.12%
Current
22.93%
Delta
-39.19%
Interest Income Growth Increased
Previous
26.95%
Current
28.49%
Delta
1.54%
Liquidity Decreased
Previous
$98.8M
Current
$97.5M
Delta
-$1.4M
Loan Growth Decreased
Previous
1.62%
Current
-0.76%
Delta
-2.38%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.